Evidence map›Paper›PMID 40867217›Full record

ArticleBrain sciences2025

Dose-Dependent Dual Effect of the Endozepine ODN on Neuronal Spiking Activity.

Mahmoud Hazime, Marion Gasselin, Michael Alasoadura, Juliette Leclerc, Benjamin Lefranc, Magali Basille-Dugay, Celine Duparc, David Vaudry, Jérôme Leprince, Julien Chuquet

Abstract read
In one paragraph

Article in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahmoud HazimeUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.
Marion GasselinUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.
Michael AlasoaduraUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.
Juliette LeclercUniv Rouen Normandie, Normandie Univ, GRHVN UR3830, F-76000 Rouen, France.ORCID 0000-0003-3012-3426
Benjamin LefrancUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.
Magali Basille-DugayUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.ORCID 0000-0001-7666-2594
Celine DuparcUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.ORCID 0000-0002-7301-6287
David VaudryUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.
Jérôme LeprinceUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.ORCID 0000-0002-7814-9927
Julien ChuquetUniv Rouen Normandie, Inserm, Normandie Univ, NORDIC UMR 1239, F-76000 Rouen, France.ORCID 0000-0002-0972-6874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesEndozepines known as the endogenous ligands of benzodiazepine-binding sites, include the diazepam binding inhibitor (DBI) and its processing products, the triakontatetraneuropeptide (TTN) and the octadecaneuropeptide (ODN). Despite indisputable evidence of the binding of ODN on GABA

methodsSpontaneous neuronal spikes were recorded by means of an extracellular pipette, in the vicinity of which ODN was micro-infused, either at a high dose (10

resultsODN at a high dose induced a significant increase in neuronal spiking. This effect could be antagonized by the GABA

conclusionOur results confirm the versatility of ODN in the control of GABA transmission, but suggest that its PAM-like effect is, at least in part, mediated via an astrocytic non-GABA

Indexed as

astrocytesendozepineGABAneuropeptides

Identifiers

PMID40867217
PMCPMC12384177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.